Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/15897551http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/15897551http://www.w3.org/2000/01/rdf-schema#comment"

Purpose

To analyze the occurrence of promoter hypermethylation in primary cutaneous T-cell lymphoma (CTCL) on a genome-wide scale, focusing on epigenetic alterations with pathogenetic significance.

Materials and methods

DNA isolated from biopsy specimens of 28 patients with CTCL, including aggressive CTCL entities (transformed mycosis fungoides and CD30-negative large T-cell lymphoma) and an indolent entity (CD30-positive large T-cell lymphoma), were investigated. For genome-wide DNA methylation screening, differential methylation hybridization using CpG island microarrays was applied, which allows simultaneous detection of the methylation status of 8640 CpG islands. Bisulfite sequence analysis was applied for confirmation and detection of hypermethylation of eight selected tumor suppressor genes.

Results

The DNA methylation patterns of CTCLs emerging from differential methylation hybridization analysis included 35 CpG islands hypermethylated in at least four of the 28 studied CTCL samples when compared with benign T-cell samples. Hypermethylation of the putative tumor suppressor genes BCL7a (in 48% of CTCL samples), PTPRG (27%), and thrombospondin 4 (52%) was confirmed and demonstrated to be associated with transcriptional downregulation. BCL7a was hypermethylated at a higher frequency in aggressive (64%) than in indolent (14%) CTCL entities. In addition, the promoters of the selected tumor suppressor genes p73 (48%), p16 (33%), CHFR (19%), p15 (10%), and TMS1 (10%) were hypermethylated in CTCL.

Conclusion

Malignant T cells of patients with CTCL display widespread promoter hypermethylation associated with inactivation of several tumor suppressor genes involved in DNA repair, cell cycle, and apoptosis signaling pathways. In view of this, CTCL may be amenable to treatment with demethylating agents."xsd:string
http://purl.uniprot.org/citations/15897551http://purl.org/dc/terms/identifier"doi:10.1200/jco.2005.11.353"xsd:string
http://purl.uniprot.org/citations/15897551http://purl.uniprot.org/core/author"Tensen C.P."xsd:string
http://purl.uniprot.org/citations/15897551http://purl.uniprot.org/core/author"Huang T.H."xsd:string
http://purl.uniprot.org/citations/15897551http://purl.uniprot.org/core/author"Dijkman R."xsd:string
http://purl.uniprot.org/citations/15897551http://purl.uniprot.org/core/author"Mulder A.A."xsd:string
http://purl.uniprot.org/citations/15897551http://purl.uniprot.org/core/author"Zoutman W.H."xsd:string
http://purl.uniprot.org/citations/15897551http://purl.uniprot.org/core/author"Willemze R."xsd:string
http://purl.uniprot.org/citations/15897551http://purl.uniprot.org/core/author"van der Velden P.A."xsd:string
http://purl.uniprot.org/citations/15897551http://purl.uniprot.org/core/author"Vermeer M.H."xsd:string
http://purl.uniprot.org/citations/15897551http://purl.uniprot.org/core/author"van Doorn R."xsd:string
http://purl.uniprot.org/citations/15897551http://purl.uniprot.org/core/author"Yan P.S."xsd:string
http://purl.uniprot.org/citations/15897551http://purl.uniprot.org/core/author"Commandeur S."xsd:string
http://purl.uniprot.org/citations/15897551http://purl.uniprot.org/core/author"de Menezes R.X."xsd:string
http://purl.uniprot.org/citations/15897551http://purl.uniprot.org/core/date"2005"xsd:gYear
http://purl.uniprot.org/citations/15897551http://purl.uniprot.org/core/name"J Clin Oncol"xsd:string
http://purl.uniprot.org/citations/15897551http://purl.uniprot.org/core/pages"3886-3896"xsd:string
http://purl.uniprot.org/citations/15897551http://purl.uniprot.org/core/title"Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73."xsd:string
http://purl.uniprot.org/citations/15897551http://purl.uniprot.org/core/volume"23"xsd:string
http://purl.uniprot.org/citations/15897551http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/15897551
http://purl.uniprot.org/citations/15897551http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/15897551
http://purl.uniprot.org/uniprot/Q4VC05#attribution-C934394F9E3CDDB3DFC34775BAE81CA0http://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/15897551
http://purl.uniprot.org/uniprot/#_A9QVW2-mappedCitation-15897551http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15897551
http://purl.uniprot.org/uniprot/#_B7Z3T1-mappedCitation-15897551http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15897551
▶